Expert panel pushes USA TODAY’s COVID-19 vaccine clock ahead on positive news, but logistical challenges loom in getting doses to Americans.
Author: Elizabeth Weise and Karen Weintraub, USA TODAY
Johnson & Johnson pauses COVID-19 vaccine trial after unexplained illness, the second US trial now on hold
The Phase 3 clinical trial was temporarily halted Monday because of an unexplained illness in one of the participants, Johnson & Johnson said.
Trump is receiving lots of medical care. Some doctors wonder if it’s too much.
All treatments carry risks, and any one of the therapies Trump is taking might be harmful alone or in combination with other therapies, the doctors said.
Data, data and more data will make a coronavirus vaccine safe, USA TODAY’s vaccine panel says
USA TODAY’s expert panel sees steady progress toward a safe and effective COVID vaccine, urge public’s patience as trials proceed and data comes in.
We’re one-third of the way to a widely available coronavirus vaccine, experts say
USA TODAY created a panel of nationally known experts to estimate how far we are from when a COVID-19 vaccine will be available to all Americans.